Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Europe (Primary) | PRIMARYEUR | Univ | 6,295 | 19,554,576 | -0.35% | 0.00% | 0.82% | 10.23% | 7.08% | 10.34% |
| Healthcare | HEALTHCARE | Sector | 576 | 2,120,153 | -0.85% | -0.64% | -2.87% | 6.55% | -4.60% | -13.61% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 183 | 1,618,104 | -1.13% | -0.69% | -3.65% | 6.04% | -5.18% | -18.73% |
| Other Biopharmaceuticals | BIOPHARMAOTHER | Industry | 59 | 1,222,704 | -0.96% | -0.13% | -1.80% | 5.23% | 0.70% | -5.03% |
Show
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS | GENIL.E:TURGENIL.E:TUR | Stock | 1 | 1,322 | 5.65% | 8.96% | 28.81% | 19.66% | 54.38% | 151.42% |
| Camurus AB | CAMX:SWECAMX:SWE | Stock | 1 | 4,102 | -0.95% | 1.34% | 11.65% | 25.44% | 16.32% | 3.50% |
| Indivior PLC | INDV:GBRINDV:GBR | Stock | 1 | 1,926 | -1.37% | 2.04% | 10.67% | 63.26% | 21.48% | 38.51% |
| Grifols SA | GRF:ESPGRF:ESP | Stock | 1 | 9,184 | -0.13% | 7.73% | 9.45% | 39.91% | 30.94% | 26.08% |
| Alkaloid AD Skopje | ALK:MKDALK:MKD | Stock | 1 | 721 | -0.01% | -0.01% | 7.55% | 1.03% | -5.37% | 28.52% |
| Biotest AG | BIO:DEUBIO:DEU | Stock | 1 | 1,992 | 0.00% | 5.34% | 7.43% | 2.36% | 4.33% | 3.33% |
| Sandoz Group AG | SDZ:CHESDZ:CHE | Stock | 1 | 24,419 | 0.80% | 3.25% | 6.99% | 46.09% | 20.32% | 31.71% |
| Allergy Therapeutics Plc | AGY:GBRAGY:GBR | Stock | 1 | 511 | 0.00% | -1.23% | 6.67% | 40.35% | 6.67% | 45.45% |
| KRKA dd | KRKG:SVNKRKG:SVN | Stock | 1 | 7,078 | 0.00% | 2.31% | 6.12% | 18.40% | 40.49% | 48.49% |
| ALK-Abello A/S | ALK.B:DNKALK.B:DNK | Stock | 1 | 6,680 | -0.97% | 1.78% | 6.07% | 47.16% | 26.86% | 25.55% |
| UCB SA | UCB:BELUCB:BEL | Stock | 1 | 37,634 | -1.07% | 0.35% | 5.40% | 20.59% | -10.18% | 22.61% |
| Orion Oyj | ORNBV:FINORNBV:FIN | Stock | 1 | 10,764 | -0.45% | 0.46% | 4.19% | 37.57% | 51.45% | 65.31% |
| Faes Farma SA | FAE:ESPFAE:ESP | Stock | 1 | 1,636 | -1.31% | 0.44% | 3.91% | 22.07% | 37.42% | 34.17% |
| Chemical Works of Gedeon Richter Plc | RICHT:HUNRICHT:HUN | Stock | 1 | 5,451 | -0.49% | 0.20% | 0.60% | 3.65% | -0.34% | 8.25% |
| Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,295 | 19,554,576 | -0.32% | -0.12% | -0.20% | 8.52% | 6.72% | 9.73% |
| Novartis AG | NOVN:CHENOVN:CHE | Stock | 1 | 234,677 | -0.38% | -1.69% | -0.32% | 11.58% | 10.41% | 0.22% |
| argenx SE | ARGX:BELARGX:BEL | Stock | 1 | 33,905 | -1.31% | 3.64% | -0.43% | -9.25% | -24.96% | 12.17% |
| Dermapharm Holding SE | DMP:DEUDMP:DEU | Stock | 1 | 2,158 | 0.29% | -1.71% | -0.65% | -5.79% | -11.88% | -0.23% |
| Bayer AG | BAYN:DEUBAYN:DEU | Stock | 1 | 31,131 | -0.71% | 0.50% | -0.94% | 31.80% | 32.34% | 2.87% |
| Laboratorios Farmaceúticos Rovi SA | ROVI:ESPROVI:ESP | Stock | 1 | 3,228 | -0.37% | 0.09% | -1.78% | 10.43% | -8.31% | -34.96% |
| Other Biopharmaceuticals | BIOPHARMAOTHER | Industry | 59 | 1,222,704 | -0.96% | -0.13% | -1.80% | 5.23% | 0.70% | -5.03% |
| AstraZeneca PLC | AZN:GBRAZN:GBR | Stock | 1 | 217,859 | -1.56% | 1.51% | -2.98% | 1.71% | 0.01% | -12.49% |
| Roche Holding AG | RO:CHERO:CHE | Stock | 1 | 268,380 | -1.38% | -0.88% | -3.43% | 5.05% | -1.47% | 0.30% |
| Sanofi | SAN:FRASAN:FRA | Stock | 1 | 120,269 | -1.01% | -0.76% | -3.70% | -5.76% | -11.79% | -6.52% |
| Merck KGaA | MRK:DEUMRK:DEU | Stock | 1 | 55,482 | 0.14% | -1.43% | -4.06% | -5.81% | -21.85% | -27.51% |
| Recordati SpA | REC:ITAREC:ITA | Stock | 1 | 12,450 | -3.52% | -2.71% | -4.75% | 9.15% | -3.23% | 4.53% |
| Hikma Pharmaceuticals Plc | HIK:GBRHIK:GBR | Stock | 1 | 5,875 | 0.81% | 0.76% | -5.10% | 6.53% | -0.05% | 10.77% |
| GSK Plc | GSK:GBRGSK:GBR | Stock | 1 | 76,694 | -1.54% | -0.81% | -5.59% | 7.31% | 8.11% | -4.16% |
| Haleon Plc | HLN:GBRHLN:GBR | Stock | 1 | 44,039 | -1.03% | -2.10% | -7.06% | -2.94% | 0.23% | 10.53% |
* Colors indicate performance relative to the benchmark.